Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
RWLK

RWLK - ReWalk Robotics Ltd Stock Price, Fair Value and News

5.10USD0.00 (0.00%)Delayed

Market Summary

RWLK
USD5.100.00
Delayed
0.00%

RWLK Stock Price

View Fullscreen

RWLK RSI Chart

RWLK Valuation

Market Cap

44.8M

Price/Earnings (Trailing)

-1.86

Price/Sales (Trailing)

3.24

EV/EBITDA

-1

Price/Free Cashflow

-1.93

RWLK Price/Sales (Trailing)

RWLK Profitability

Operating Margin

8.83%

EBT Margin

-174.09%

Return on Equity

-59.37%

Return on Assets

-43.67%

Free Cashflow Yield

-51.74%

RWLK Fundamentals

RWLK Revenue

Revenue (TTM)

13.9M

Rev. Growth (Yr)

329.51%

Rev. Growth (Qtr)

-23.26%

RWLK Earnings

Earnings (TTM)

-24.1M

Earnings Growth (Yr)

-45.8%

Earnings Growth (Qtr)

-11.72%

Breaking Down RWLK Revenue

Last 7 days

10.4%

Last 30 days

460.2%

Last 90 days

568.0%

Trailing 12 Months

665.8%

How does RWLK drawdown profile look like?

RWLK Financial Health

Current Ratio

3.25

Debt/Equity

0

Debt/Cashflow

-150.05

RWLK Investor Care

Shares Dilution (1Y)

1.09%

Diluted EPS (TTM)

-2.83

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20240000
20235.9M5.6M8.4M13.9M
20225.5M5.7M4.6M5.5M
20214.9M4.7M5.9M6.0M
20204.1M4.8M4.4M4.4M
20196.5M5.7M5.3M4.9M
20186.8M6.6M6.5M6.5M
20176.3M7.5M7.8M7.8M
20165.2M5.4M5.6M5.9M
20153.9M3.8M3.8M3.7M
20142.2M2.8M3.4M4.0M
20130001.6M
2012000972.0K

Tracking the Latest Insider Buys and Sells of ReWalk Robotics Ltd

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 20, 2023
lind global fund ii lp
bought
8,760
0.73
12,000
-
Nov 17, 2023
lind global fund ii lp
bought
31,329
0.73
42,917
-
Nov 14, 2023
lind global fund ii lp
bought
49,516
0.68
72,818
-
Sep 26, 2023
lind global fund ii lp
sold
-3,521,840
0.7
-5,031,200
-
Sep 26, 2023
lind global fund ii lp
bought
3,521,840
0.7
5,031,200
-
Sep 13, 2023
richner randel
acquired
-
-
59,595
-
Sep 13, 2023
turk joseph e jr
acquired
-
-
59,595
-
Sep 13, 2023
jasinski lawrence j
acquired
-
-
200,000
chief executive officer
Sep 13, 2023
levy hadar
acquired
-
-
59,595
-
Sep 13, 2023
poduska john william sr
acquired
-
-
59,595
-

1–10 of 50

Which funds bought or sold RWLK recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 16, 2024
JANE STREET GROUP, LLC
sold off
-100
-12,149
-
-%
May 15, 2024
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
new
-
5.00
5.00
-%
May 15, 2024
Royal Bank of Canada
sold off
-100
-
-
-%
May 15, 2024
CITADEL ADVISORS LLC
new
-
60,307
60,307
-%
May 15, 2024
MORGAN STANLEY
sold off
-100
-13,623
-
-%
May 15, 2024
MORGAN STANLEY
new
-
24,283
24,283
-%
May 15, 2024
MERCER GLOBAL ADVISORS INC /ADV
sold off
-100
-23,000
-
-%
May 15, 2024
BANK OF AMERICA CORP /DE/
new
-
4,006
4,006
-%
May 15, 2024
Royal Bank of Canada
new
-
-
-
-%
May 15, 2024
TWO SIGMA SECURITIES, LLC
sold off
-100
-13,750
-
-%

1–10 of 42

Are Funds Buying or Selling RWLK?

Are funds buying RWLK calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own RWLK
No. of Funds

Unveiling ReWalk Robotics Ltd's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Sep 28, 2023
lind global fund ii lp
16.5%
9,890,010
SC 13D/A
Mar 09, 2023
lind global fund ii lp
7.7%
4,568,050
SC 13D/A
Feb 22, 2023
lind global fund ii lp
7.2%
4,449,433
SC 13D
Feb 13, 2023
lind global fund ii lp
8.1%
5,050,853
SC 13G/A
Feb 15, 2022
armistice capital, llc
4.1%
2,650,800
SC 13G/A
Feb 11, 2022
intracoastal capital, llc
3.7%
2,385,280
SC 13G/A
Feb 11, 2022
lind global fund ii lp
5.4%
3,387,487
SC 13G/A
Oct 04, 2021
lind global fund ii lp
2.6%
1,637,286
SC 13G
Feb 16, 2021
armistice capital, llc
5.6%
1,394,944
SC 13G
Feb 16, 2021
cvi investments, inc.
2.6%
648,097
SC 13G/A

Recent SEC filings of ReWalk Robotics Ltd

View All Filings
Date Filed Form Type Document
May 15, 2024
8-K
Current Report
May 15, 2024
10-Q
Quarterly Report
Apr 29, 2024
10-K/A
Annual Report
Apr 22, 2024
4
Insider Trading
Apr 22, 2024
3
Insider Trading
Apr 19, 2024
8-K
Current Report
Apr 04, 2024
8-K
Current Report
Apr 03, 2024
8-K
Current Report
Feb 27, 2024
8-K
Current Report
Feb 27, 2024
10-K
Annual Report

Peers (Alternatives to ReWalk Robotics Ltd)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
181.0B
40.3B
-1.75% -4.07%
32.18
4.49
-2.84% -3.08%
68.3B
19.7B
1.78% -6.05%
51.24
3.46
4.82% -17.56%
20.4B
3.9B
-9.57% -7.50%
44.2
5.22
5.72% 46.72%
18.0B
14.9B
-10.73% -18.01%
6.79
1.21
2.98% 207.68%
MID-CAP
9.8B
3.5B
6.68% 24.08%
31.27
2.76
6.16% 35.06%
9.6B
12.5B
6.31% -2.51%
24.63
0.77
-0.61% -18.83%
8.4B
2.6B
1.13% -22.65%
-26.02
3.22
-6.25% -68.62%
5.9B
3.9B
-6.79% -30.12%
-62.84
1.49
0.23% 91.03%
3.4B
387.1M
0.52% 31.17%
-216.3
8.9
30.82% 65.57%
2.3B
6.6B
0.19% -5.50%
11.93
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
5.94% -10.00%
-1.91
0.41
7.94% -1661.78%
376.6M
169.3M
-1.13% -2.23%
-4.9
2.23
7.49% -244.90%
241.9M
324.0M
-4.58% -37.15%
-1.26
0.75
-3.19% -337.41%
56.1M
50.5M
22.73% -73.49%
-2.46
1.11
14.25% -10.06%
1.0M
3.7M
-71.13% 32.26%
-0.09
0.28
5.77% 8.23%

ReWalk Robotics Ltd News

Latest updates
InvestorPlace • 3 months ago

ReWalk Robotics Ltd Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q2
Revenue-23.3%5,283,0006,884,0004,403,0002,870,0001,337,0001,230,0002,179,000886,0001,570,000876,0001,242,0001,972,0001,436,0001,316,0001,218,000747,0001,668,000760,0001,181,0001,234,000877,000
Cost Of Revenue-12.5%3,888,0004,441,0003,540,000-761,000659,0001,506,000665,000824,000611,000913,000832,000709,000609,000816,000355,000646,000387,000465,000585,000442,000
Gross Profit-42.9%1,395,0002,443,000863,000-576,000571,000673,000221,000746,000265,000329,0001,140,000727,000707,000402,000392,0001,022,000373,000716,000649,000435,000
Operating Expenses-8.0%7,897,0008,580,0008,805,000-5,734,0004,946,0005,678,0005,654,0005,122,0004,553,0004,160,0003,802,0003,868,0003,728,0003,183,0003,461,0003,574,0003,975,0003,923,0003,680,0004,670,000
  S&GA Expenses3.5%5,014,0004,846,0004,088,000-2,504,0002,484,0002,723,0002,588,0002,347,0002,184,0001,888,0001,821,0001,613,0001,671,0001,213,0001,507,0001,353,0001,681,0001,596,0001,453,0001,531,000
  R&D Expenses-2.0%1,291,0001,318,0001,262,000-816,000752,0001,103,0001,065,000956,000907,000696,000638,000810,000795,000764,000756,000954,000985,0001,056,0001,018,0001,860,000
EBITDA Margin-9.0%-1.72-1.58-1.84-2.28-3.39-3.22-3.43-3.88-2.65-2.48-2.07-1.80-2.40--------
Interest Expenses500.0%8,000-2,0003,000-10,000----------------
Income Taxes107.7%6,000-78,000--42,00024,000377,00026,00026,00038,00054,000-14,0009,00045,000-34,00025,00068,000-8,0003,000-2,000-1,000
Earnings Before Taxes-9.7%-6,270,000-5,717,000-7,531,000--4,600,000-4,297,000-4,936,000-5,434,000-4,420,000-4,312,000-3,804,000-2,689,000-3,132,000-3,017,000-2,979,000-3,311,000-2,787,000-3,848,000-3,572,000-3,391,000-4,588,000
EBT Margin-8.9%-1.74-1.60-1.92-2.30-3.42-3.25-3.47-3.93-2.69-2.52-2.12-1.99-2.64--------
Net Income-11.7%-6,300,000-5,639,000-7,531,000--4,642,000-4,321,000-5,313,000-5,460,000-4,446,000-4,350,000-3,858,000-2,675,000-3,141,000-3,062,000-2,945,000-3,336,000-2,855,000-3,840,000-3,575,000-3,389,000-4,587,000
Net Income Margin-8.9%-1.74-1.60-1.96-2.36-3.50-3.33-3.55-3.96-2.71-2.54-2.13-1.99-2.65--------
Free Cashflow-68.2%-7,673,000-4,563,000-7,485,000-3,467,000-3,467,000-5,233,000-3,913,000-4,608,000-3,684,000-5,711,000-2,585,000-2,580,000-3,169,000--------
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-12.6%55,21863,19269,21965,81168,97874,23680,77185,79889,99894,75098,71871,70574,56128,06726,23422,70625,21724,37228,42631,97217,036
  Current Assets-16.4%32,78639,22244,41663,84266,87672,51078,89583,75387,80692,52196,33069,19571,91925,24823,30519,69621,96221,07325,13728,51613,414
    Cash Equivalents-24.9%21,10428,08332,60058,20061,88367,89674,68279,49183,33989,05091,93164,93968,10821,05418,73614,74717,33216,99221,14724,8649,674
  Inventory7.2%6,0595,6536,0433,0383,0272,9293,3303,0983,2322,9893,0663,3463,4933,5423,7073,4553,3403,1232,9802,6612,478
  Net PPE-4.4%1,2061,2621,047129160196237281307284303355392437474447485501480453532
  Goodwill0%7,5387,5387,538------------------
Liabilities-12.5%14,60316,68217,4436,8375,4596,0715,1814,8854,8125,3675,7255,6275,5426,2939,44510,80712,13413,59214,31114,70414,981
  Current Liabilities-14.4%10,09211,79512,8145,4423,8834,7824,2203,7993,6204,0384,3814,2024,0224,6687,6458,84710,35110,1689,4598,3707,271
  Long Term Debt---------------154218-1,5272,9834,3735,699
    LT Debt, Current---------------3,2804,5485,6995,4384,4433,4932,587
    LT Debt, Non Current---------------154218-1,5272,9834,3735,699
Shareholder's Equity-12.7%40,61546,51051,77658,97463,51968,16575,59080,91385,18689,38392,99366,07869,01921,77416,78911,89913,08310,78014,11517,2682,055
  Retained Earnings-2.7%-242,200-235,883-230,200-222,700-218,071-213,750-208,400-202,977-198,500-194,181-190,323-187,648-184,507-181,445-178,500-175,164-172,309-168,469-164,894-161,505-156,918
  Additional Paid-In Capital0.1%281,483281,109280,742280,455280,152279,857279,519279,215279,054278,903278,658250,332250,141201,392193,937186,070184,489178,745178,506178,270158,720
Shares Outstanding0.2%8,6028,5878,5758,4788,4978,5848,9718,9318,9286,8486,6536,589---------
Float----35,050---58,467---77,594---27,393,283---30,393,283-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-71.1%-7,673-4,484-7,483-3,467-5,233-3,913-4,601-3,669-5,708-2,566-2,563-3,167-3,173-2,458-2,598-3,192-4,341-3,590-3,269-3,703-4,253
  Share Based Compensation2.1%381373333318304347320173153234231200168205232113199239236314319
Cashflow From Investing100.0%--79.00-18,070----7.00-15.00-3.00-19.00-17.00-2.00-9.00--58.00-6.00-9.00-14.00---
Cashflow From Financing----6.00-215-771-2,317-183---29629,572-50,2364,7766,6456134,690-551-44018,8933,580
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

RWLK Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Revenues$ 5,283$ 1,230
Cost of revenues3,888659
Gross profit1,395571
Operating expenses:  
Research and development, net1,291752
Sales and marketing5,0142,484
General and administrative1,5921,710
Total operating expenses7,8974,946
Operating loss(6,502)(4,375)
Financial income, net23278
Loss before income taxes(6,270)(4,297)
Taxes on income624
Net loss$ (6,276)$ (4,321)
Net loss per ordinary share, basic$ (0.73)$ (0.51)
Net loss per ordinary share, diluted$ (0.73)$ (0.51)
Weighted average number of shares used in computing net loss per ordinary share, basic8,590,0888,502,217
Weighted average number of shares used in computing net loss per ordinary share, diluted[1]8,590,0888,502,217
[1]Reflects our one-for-seven reverse share split that became effective on March 15, 2024. See Note 8a to the condensed consolidated financial statements.

RWLK Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
CURRENT ASSETS  
Cash and cash equivalents$ 20,744$ 28,083
Trade receivable, net of credit losses of $306 and $328, respectively3,4913,120
Prepaid expenses and other current assets2,4922,366
Inventories6,0595,653
Total current assets32,78639,222
LONG-TERM ASSETS  
Restricted cash and other long-term assets432784
Operating lease right-of-use assets1,5621,861
Property and equipment, net1,2061,262
Intangible assets11,69412,525
Goodwill7,5387,538
Total long-term assets22,43223,970
Total assets55,21863,192
CURRENT LIABILITIES  
Trade payables4,2785,069
Employees and payroll accruals1,4872,034
Deferred revenues1,4301,504
Current maturities of operating leases liability1,2451,296
Earnout liability579576
Other current liabilities1,0731,316
Total current liabilities10,09211,795
LONG-TERM LIABILITIES  
Earnout liability2,7092,716
Deferred revenues1,3641,506
Non-current operating leases liability354607
Other long-term liabilities8458
Total long-term liabilities4,5114,887
Total liabilities14,60316,682
COMMITMENTS AND CONTINGENT LIABILITIES
Shareholders' equity:  
Ordinary share of NIS 1.75 par value-Authorized: 25,000,000 shares at March 31, 2024 and December 31, 2023; Issued: 9,176,502 and 9,161,798 shares at March 31, 2024 and December 31, 2023, respectively; Outstanding: 8,601,844 and 8,587,140 shares as of March 31, 2024 and December 31, 2023 respectively[1]4,4944,487
Additional paid-in capital281,483281,109
Treasury Shares at cost, 574,658 ordinary shares at March 31, 2024 and December 31, 2023[1](3,203)(3,203)
Accumulated deficit(242,159)(235,883)
Total shareholders' equity40,61546,510
Total liabilities and shareholders' equity$ 55,218$ 63,192
[1]Reflects our one-for-seven reverse share split that became effective on March 15, 2024. See Note 8a to the condensed consolidated financial statements.
RWLK
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
 CEO
 WEBSITErewalk.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES56

ReWalk Robotics Ltd Frequently Asked Questions


What is the ticker symbol for ReWalk Robotics Ltd? What does RWLK stand for in stocks?

RWLK is the stock ticker symbol of ReWalk Robotics Ltd. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ReWalk Robotics Ltd (RWLK)?

As of Tue Apr 30 2024, market cap of ReWalk Robotics Ltd is 44.82 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of RWLK stock?

You can check RWLK's fair value in chart for subscribers.

What is the fair value of RWLK stock?

You can check RWLK's fair value in chart for subscribers. The fair value of ReWalk Robotics Ltd is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of ReWalk Robotics Ltd is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for RWLK so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is ReWalk Robotics Ltd a good stock to buy?

The fair value guage provides a quick view whether RWLK is over valued or under valued. Whether ReWalk Robotics Ltd is cheap or expensive depends on the assumptions which impact ReWalk Robotics Ltd's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RWLK.

What is ReWalk Robotics Ltd's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 30 2024, RWLK's PE ratio (Price to Earnings) is -1.86 and Price to Sales (PS) ratio is 3.24. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RWLK PE ratio will change depending on the future growth rate expectations of investors.